Results for this period
Interim period (second quarter)2025年4月1日〜2025年9月30日ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
パチスロの保通協等による検定試験の適合率が低調に推移したことにより「RS1」の量産出荷が一時的に弱含みとなった。減収に加え「Di1」の開発費143百万円を計上し、投資有価証券評価損19百万円も計上した。
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2025年4月1日〜2025年9月30日 |
| Net Sales | ¥902 million (YoY -41.2%) |
| Operating profit | ¥-299 million |
| Ordinary income | ¥-292 million |
| Profit attributable to owners of the parent | ¥-313 million |
| Net income per share | △99.72円 |
| Equity ratio | End of the current fiscal period 87.7 / End of previous period 88.2 |
| Total assets | ¥3,758 million |
| Net assets | ¥3,297 million |
| Cash flows from operating activities | ¥-458 million |
| Cash flows from investing activities | ¥-29 million |
| Cash and cash equivalents at end of period | ¥2,043 million |
| Full-year earnings forecast | Net Sales ¥3,250 million (YoY +5.6%) / Operating profit ¥20 million (YoY -92.5%) / Ordinary income ¥25 million (YoY -90.8%) / Profit attributable to owners of the parent ¥20 million (YoY -87.3%) |
| Annual Dividend Forecast | ¥0 → ¥0(0.0%) |
| Depreciation and amortization | ¥9,650 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Not disclosed / Extraordinary loss Impairment Loss on Investment Securities ¥19,979 thousand |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 3,152,400 shares |
| Treasury Shares at Period-End | 7,240株 |
| Factors Behind Changes in Business Performance | パチスロの保通協等による検定試験の適合率が低調に推移したことにより「RS1」の量産出荷が一時的に弱含みとなった。減収に加え「Di1」の開発費143百万円を計上し、投資有価証券評価損19百万円も計上した。 |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.パチスロの保通協等による検定試験の適合率が低調に推移し、「RS1」の量産出荷が一時的に弱含んだことが減収の主要因。営業損失は減収に加え、次世代エッジAI半導体「Di1」の開発費143百万円を計上したことによる。親会社株主に帰属する中間純損失は、投資有価証券評価損19百万円を計上したことによる。